Overview

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Purpose: This study will assess the safety and efficacy of Endostar combined with chemotherapy in osteosarcoma patients.
Phase:
Phase 2
Details
Lead Sponsor:
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Treatments:
Endostar protein